PPD Earns Gold Award for Excellence in Employee Learning and Development

WILMINGTON, N.C. — PPD, Inc. (Nasdaq: PPD) has been recognized with two global excellence awards for its effective learning programs, honoring the company’s high-performing employee development initiatives supporting delivery of global operational excellence and innovative solutions to customers. For the second consecutive year, PPD received two Brandon Hall Group Human Capital Management (HCM) “Excellence in Learning” Awards. This year’s honors include a…

Read More

PPD Receives Award Recognizing Employee Talent Development

WILMINGTON, N.C. — PPD, Inc. (Nasdaq: PPD) has been recognized as one of the best in the world for its successful employee learning and development programs by the Association for Talent Development (ATD), a global organization that empowers and supports professionals to develop talent in the workplace. PPD is a recipient of the 2021 ATD BEST Awards, which…

Read More

PPD Named ‘Most Innovative CRO’ by Triangle Business Journal

PPD

Honors PPD’s development and implementation of innovative customer solutions during COVID-19 pandemic WILMINGTON, N.C.  has been named “Most Innovative CRO” by North Carolina’s Triangle Business Journal, recognizing the global contract research organization’s strong performance in a year shaped by the COVID-19 pandemic. PPD’s significant investments to expand capabilities for patient recruitment for clinical trials, investigator sites, laboratories,…

Read More

PPD Opens Multipurpose Clinical Research Laboratory in Suzhou, China

PPD

SUZHOU, CHINA – PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, held a grand opening ceremony for its new multipurpose laboratory in Suzhou, China, to support Western and China-based pharmaceutical and biotech companies managing China research studies. The 67,000-square-foot facility in the Suzhou New District, Jiangsu Province, offers bioanalytical, biomarker and vaccine laboratory services to…

Read More

CRO Leadership Awards Recognize PPD for Excellence for 10th Consecutive Year

PPD

WILMINGTON, N.C. – PPD, Inc. (Nasdaq: PPD) has been recognized for excellence in the CRO Leadership Awards for the 10th consecutive year, earning praise for its clinical research capabilities and customer compatibility in a survey of pharmaceutical and biotech professionals conducted for Clinical Leader and Life Science Leader magazines. A leading global contract research organization (CRO), PPD serves a wide range of customers with…

Read More

PPD Named “Best CRO” at Vaccine Industry Excellence Awards

PPD

WILMINGTON, N.C. – PPD, Inc. (Nasdaq: PPD) was named “Best Contract Research Organization” at the 14th annual Vaccine Industry Excellence (ViE) Awards during the 2021 World Vaccine Congress. Accelerated Enrollment Solutions (AES), a business of PPD, received the honor of “highly commended” in the category of “Best Clinical Trial Network.” “When it comes to helping customers develop safe and effective vaccines, our dedicated…

Read More

PPD to Expand GMP Lab in Ireland to Enhance Biopharmaceutical Testing Capabilities

PPD

Adding cell and gene therapy capabilities to support growing customer need WILMINGTON, N.C. – PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, is expanding its Athlone, Ireland, GMP (good manufacturing practices) laboratory, significantly increasing the size of its current facility and adding cell and gene therapy testing to the operation’s portfolio of services. The expansion…

Read More

PPD and Science 37® Strengthen Collaboration to Advance Decentralized Clinical Trials and Accelerate Development

PPD

Innovative approach enables PPD to deploy studies utilizing Science 37’s SaaS Platform WILMINGTON, N.C. & LOS ANGELES, PPD, Inc. (Nasdaq: PPD), a leading global contract research organization (CRO), and Science 37, developer of the Decentralized Clinical Trial Operating System™ (DCT OS), today announced an innovative collaboration in which PPD will be fully enabled to design, build, test, implement and execute…

Read More

Thermo Fisher Scientific set to acquire PPD

PPD

Further expands service offering to pharma and biotech customers WALTHAM, Mass. and WILMINGTON, N.C., — Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, and PPD, Inc. (Nasdaq: PPD) (“PPD”), a leading global provider of clinical research services to the pharma and biotech industry, today announced that their boards of directors have approved…

Read More

PPD Announces First Quarter 2021 Earnings Conference Call

PPD

WILMINGTON, N.C., a leading global contract research organization, will host a conference call on Wednesday, April 28, 2021, at 8 a.m. (U.S. Eastern Time) to discuss its first quarter 2021 financial results. Investors and other interested parties may listen to a live webcast of the conference call by logging on to the investors section of PPD’s…

Read More